Clinical trial
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive…
NCT00234104 · Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00234104 |
|---|---|
| Title | A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Dose Response of OPC-41061 in Congestive Heart Failure Patients With Extracellular Volume Expansion |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Edema |
| Intervention type | Drug |
| Interventions | OPC-41061(Tolvaptan) |
| Enrollment | 122 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Oct 6, 2005 |
| Last update posted | Dec 25, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: